T1 Condition 1168 1171 TIM
T2 Species 580 584 mice
T3 Condition 593 613 intracranial gliomas
T4 Condition 1133 1136 TIM
T5 Condition 634 673 ± murine anti–PD-1 monoclonal antibody 
T6 Condition 45 50 tumor
T7 Protein 268 270 DC
T8 Condition 888 893 tumor
T9 Protein 1593 1596 TIL
T10 Level 1019 1050 TIMs rather than by tumor cells
T11 Condition 1294 1299  mAb 
T12 Condition 421 426 tumor
T13 Protein 138 141 GBM
T14 Protein 619 621 DC
T15 Protein 985 988 GBM
T16 Gene 1492 1500 PD-1 mAb
T17 Condition 1986 1990 PD-1
T18 Protein 1246 1249 TIL
T19 Gene 1290 1298 PD-1 mAb
T20 Condition 1974 1981 CSF-1Ri
T21 Protein 1584 1588 TILs
T22 Protein 497 501 TILs
T23 Condition 741 748 CSF-1Ri
T24 Condition 1152 1159 CSF-1Ri
T25 Protein 1584 1587 TIL
T26 Condition 1303 1310 CSF-1Ri
T27 Condition 465 470 tumor
T28 Condition 1492 1496 PD-1
T29 Gene 1986 1994 PD-1 mAb
T30 Condition 838 841 TIM
T31 Condition 421 495 tumor-cytolytic function of vaccine-induced tumor-infiltrating lymphocytes
T32 Condition 1039 1044 tumor
T33 Level 1133 1137 TIMs
T34 Protein 1106 1109 TIL
T35 Condition 175 180 tumor
T36 Biomarker 367 372 PD-L1
T37 Condition 1069 1073 PD-1
T38 Protein 1480 1482 DC
T39 Condition 1667 1670 TIM
T40 Biomarker 831 836 PD-L1
T41 Protein 1380 1382 DC
T42 Condition 648 652 PD-1
T43 Level 1019 1023 TIMs
T44 CL 252 266 dendritic cell
T45 CL 175 206 tumor-infiltrating myeloid cell
T46 Condition 208 211 TIM
T47 Condition 1290 1294 PD-1
T48 Protein 751 758 PLX3397
T49 Biomarker 961 966 PD-L1
T50 Protein 1502 1509 PLX3397
T51 Level 1667 1671 TIMs
T52 Protein 1926 1929 GBM
T53 Protein 869 872 TIL
T54 Protein 1724 1727 GBM
T55 Condition 678 740  blockade or a colony stimulating factor 1 receptor inhibitor 
T56 Condition 124 136 glioblastoma
T57 Protein 497 500 TIL
T58 Condition 1019 1022 TIM
R1 Relation Arg1:T6 Arg2:T13
